Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
24m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
25m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
25m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
25m agoFirst Quantum Minerals Reports First Quarter 2026 Results
25m agoDistrict Metals Announces $10 Million Private Placement Financing
Soligenix Inc logo

Soligenix Inc

About

Soligenix Inc (NASDAQ:SNGX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 2 2026
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
Mar 31 2026
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
Mar 26 2026
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
Mar 24 2026
Soligenix (SNGX) HyBryte Data To Be Presented At USCLC Workshop Ahead Of AAD Meeting
Mar 23 2026
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026

Financials

Revenue
$0
Market Cap
$11.75 M
EPS
-2.14

Community Chat

Ask AI

6ix6ixAIEvents